Inhalation of prostacyclin (PGI2) for 8 hours does not produce signs of acute pulmonary toxicity in healthy lambs

Intensive Care Medicine

Volumn 22, Issue 5, 1996, Pages 426-433

  Habler, O ^a   Kleen, M ^a   Zwissler, B ^b   Pusch, R ^a   Welte, M ^a   Vogelmeier, C ^b   Kempter, B ^b   Krombach, F ^a   Messmer, K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Aerosols; Epoprostenol; Lung; Toxicity

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; PROSTACYCLIN;

AEROSOL; ANIMAL EXPERIMENT; ARTICLE; BLEEDING TIME; BODY POSTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG TOXICITY; ENDOTRACHEAL INTUBATION; EPITHELIUM; HEMODYNAMICS; INHALATIONAL DRUG ADMINISTRATION; LAMB; LUNG ALVEOLUS; LUNG LAVAGE; LUNG TOXICITY; NEBULIZER; NONHUMAN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION; ACUTE DISEASE; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DRUG MONITORING; DRUG SCREENING; FEMALE; LUNG DISEASE; MALE; NEWBORN; PATHOLOGY; RANDOMIZATION; SHEEP; TIME;

ACUTE DISEASE; ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; ANIMALS, NEWBORN; BRONCHOALVEOLAR LAVAGE FLUID; DRUG EVALUATION, PRECLINICAL; DRUG MONITORING; EPOPROSTENOL; FEMALE; HEMODYNAMIC PROCESSES; LUNG DISEASES; MALE; RANDOM ALLOCATION; SHEEP; TIME FACTORS;

EID: 0029665240     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01712159     Document Type: Article

References (32)

1. Radermacher P, Santak B (1991) Vasodilating agents in ARDS. In: Vincent JL (ed) Update in intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 307-309
2. Sibbald WJ, Driedger AA, Myers ML, Short AI, Wells GA (1983) Biventricular function in the adult respiratory distress syndrome. Chest 84: 126-134
3. Prielipp RC, McLean R, Rosenthal MH, Pearl RG (1991) Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in experimental porcine pulmonary hypertension. Crit Care Med 19:60-67
4. Radermacher P, Santak B, Wust HJ, Tarnow J, Falke KJ (1990) Prostacyclin for the treatment of pulmonary hypertension in the adult respiratory distress syndrome: effects on pulmonary capillary pressure and ventilation-perfusion distributions. Anesthesiology 72: 238-244
5. 2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction. Eur Surg Res 25: 329-340
6. Walmrath D, Schneider T, Pilch J, Grimminger F, Seeger W (1993) Aerosolised prostacyclin in adult respiratory distress syndrome. Lancet 342:961-962
7. Bein T, Pfeifer M, Riegger G, Taeger K (1994) Continuous intraarterial measurements of oxygenation during aerosolized prostacyclin administration in severe respiratory failure (correspondence). N Engl J Med 331:335-336
8. Marggraf G, Balzerreit A, Schönfelder B, Doetsch N, Zerkowski HR, Reidemeister JC (1994) Hämodynamische Effekte von Epoprostenol als Aerosol zur selektiven pulmonalen Vasodilatation versus intravenöse Applikation nach kardiochirurgischer Intervention. Anaesthesist 43 [Suppl 1]:S209
9. 2 on gas exchange and pulmonary hemodynamics in patients with acute respiratory failure. Intensive Care Med 20 [Suppl 2]:S58
10. Bindl L, Fahnenstich H, Peukert U (1994) Aerosolised prostacyclin for pulmonary hypertension in neonates. Arch Dis Child Fetal Neonatal 71: F214-F216
11. Santak B, Schreiber M, Kuen P, Lang D, Radermacher P (1995) Prostacyclin aerosol in an infant with pulmonary hypertension. Eur J Pediatr 154:233-235
12. Walmrath D, Schneider T, Pilch J, Schermuly R, Grimminger F, Seeger W (1995) Effects of aerosolized prostacyclin in severe pneumonia. Am J Respir Crit Care Med 151:724-730
13. Zwissler B, Rank N, Jaenicke U, Schürle B, Welte M, Reichart B, Netz H, Messmer K, Peter K (1995) Selective pulmonary vasodilation by inhaled prostacyclin in a newborn with congenital heart disease and cardiopulmonary bypass. Anesthesiology 82:1512-1516
14. Pappert D, Busch T, Gerlach H, Lewandowski K, Radermacher P, Rossaint R (1995) Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome. Anesthesiology 82:1507-1511
15. Burghuber OC, Silberbauer K, Haber P, Sinzinger H, Elliott M, Leithner C (1984) Pulmonary and antiaggregatory effects of prostacyclin after inhalation and intravenous infusion. Respiration 45:450-455
16. Szczeklick A, Gryglewski RJ, Nizankowska E, Nizankowska R, Musial J (1978) Pulmonary and anti-platelet effects of intravenous and inhaled prostacyclin in man. Prostaglandins 16: 651-660
17. Parsargiklian M, Bianco S (1980) Ventilatory and cardiovascular effects of prostacyclin and 6-oxo-PGF1 alpha by inhalation. Adv Prost Thromb Res 7: 943-951
18. Hardy CC, Bradding P, Robinson C, Holgate ST (1988) Bronchoconstrictor and antibronchoconstrictor properties of inhaled prostacyclin in asthma. J Appl Physiol 64:1567-1574
19. Holt JP, Rhode EA, Kines H (1968) Ventricular volumes and body weight in mammals. Am J Physiol 215:704-715
20. Kelman GR (1966) Digital computer subroutine for the conversion of oxygen tension into saturation. J Appl Physiol 21:1375-1376
21. Rennard SI, Basset G, Lecossier D, O'Donnell K, Pinkston P, Martin P, Crystal R (1986) Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 60:532-538
22. Ludbrook J (1994) Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc Res 28:303-311
23. Bahkle YS, Ferreira SH (1985) Lung metabolism of eicosanoids: prostaglandins, prostacyclin, thromboxane, and leukotrienes. In: Fishman AP, Fisher AB (eds) Handbbok of physiology, sect. 3: the respiratory system. American Physiological Society, Bethesda, MD, pp 365-386
24. Roberts AM, Schultz HD, Green JF, Armstrong DJ, Kaufman MP, Coleridge HM, Coleridge JCG ( 1985) Reflex tracheal contraction evoked in dogs by bronchodilator prostaglandins E2 and I2. J Appl Physiol 58:1823-1831
25. Henderson RF, Rebar AH, Pickrell JA, Newton GJ (1979) Early damage indicators in the lung. III. Biochemical and cytological response of the lung to inhaled metal salts. Toxicol Appl Pharmacol 50:123-136
26. Beck BD, Brain JD, Bohannon DE (1982) An in vivo hamster bioassay to assess the toxicity of particulates for the lungs. Toxicol Appl Pharmacol 66: 9-29
27. Hubbard GB, Langlinais PC, Shimazu T, Okerberg CV, Mason AD, Pruitt BA (1991) The morphology of smoke inhalation injury in sheep. J Trauma 31: 1477-1486
28. Henderson RF (1988) Use of bronchoalveolar lavage to detect lung damage. In: Gardner DE, Crapo JD, Massaro EJ (eds) Toxicology of the lung. Raven Press, New York, pp 239-268
29. Taylor AE, Guyton AC, Bishop VS (1965) Permeability of the alveolar membrane to solutes. Circ Res 16: 353-362
30. Adams FH, Moss AJ, Fagan L (1963) The tracheal fluid in the fetal lamb. Biol Neonat 5:151-158
31. Brain JD, Beck BD (1985) Bronchoalveolar lavage. In: Witschi HP, Brain JD (eds) Toxicology of inhaled materials. Springer, Berlin Heidelberg New York, pp 203-226
32. Von Essen SG, Robbins RA, Spurzem JR, Thompson AB, McGranaghan S, Rennard SI (1991) Bronchoscopy with bronchoalveolar lavage causes neutrophil recruitment in the lower respiratory tract. Am Rev Respir Dis 144:848-854